Dostarlimab: A Breakthrough Immunotherapy Offering Surgery-Free Cancer Treatment
A groundbreaking study has revealed that the immunotherapy drug dostarlimab can effectively treat certain cancers, potentially eliminating the need for surgery, chemotherapy, or radiation. Conducted at Memorial Sloan Kettering Cancer Center, the trial focused on patients with mismatch repair-deficient (dMMR) cancers, including rectal, endometrial, and gastric cancers. Study Overview The Phase II study involved 103 […]
Continue Reading